Figure 5 : Activation of interferonγ-expressing splenocytes by PTD-J-hTERTepi and Hsp72.

Four sets of mice received treatments with PBS, 1×106 differentiated DCs, DCs with 35μg of PTD-J-hTERTepi, and DCs with 35μg of PTD-J-hTERTepi and 13μg of Hsp72, in a volume of 0.5 mL on days 0 and 7. Numbers of IFNγ expressing splenocytes were determined at day 14 using ELISPOT. Measurements were performed in triplicate.

Chuang et al.Journal of Immunotherapy Applications  2015 2:1DOI : 10.7243/2055-2394-2-1